Therapeutic targeting of cancer cell metabolism

Journal of Molecular Medicine

Volumn 89, Issue 3, 2011, Pages 205-212

  Dang, Chi V ^a   Hamaker, Max ^a   Sun, Peng ^a   Le, Anne ^a   Gao, Ping ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer therapy; Glutaminolysis; Glycolysis; Warburg effect

Indexed keywords

GLUTAMINE;

ANAEROBIC GLYCOLYSIS; CANCER CELL; CELL DEATH; CELL DIVISION; CELL METABOLISM; GLUCOSE METABOLISM; HUMAN; OXIDATIVE PHOSPHORYLATION; REVIEW;

ANIMALS; GLUTAMINE; GLYCOLYSIS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS;

EID: 79955759406     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-011-0730-x     Document Type: Review

References (36)

1. Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519-530
2. Benarroch EE (2010) Glycogen metabolism: Metabolic coupling between astrocytes and neurons. Neurology 74:919-923. doi:10.1212/WNL.0b013e3181d3e44b/ 74/11/919
3. Burke ZD, Reed KR, Phesse TJ, Sansom OJ, Clarke AR, Tosh D (2009) Liver zonation occurs through a beta-catenin-dependent, c-Myc-independent mechanism. Gastroenterology 136(2316-2324): E2311-e2313. doi:10.1053/j.gastro.2009.02.063/ S0016-5085(09) 00349-7
4. Khurana NK, Niemann H (2000) Energy metabolism in preimplantation bovine embryos derived in vitro or in vivo. Biol Reprod 62:847-856 (Pubitemid 30173796)
5. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767. doi:0092-8674(90)90186-I
6. Deberardinis RJ, Sayed N, Ditsworth D, Thompson CB (2008) Brick by brick: Metabolism and tumor cell growth. Curr Opin Genet Dev 18:54-61 (Pubitemid 351694453)
7. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70. doi:S0092-8674(00)81683-9 (Pubitemid 30046295)
8. Fukumura D, Duda DG, Munn LL, Jain RK (2010) Tumor microvasculature and microenvironment: Novel insights through intravital imaging in pre-clinical models. Microcirculation 17:206-225. doi:10.1111/j.1549-8719.2010.00029.x/DOI MICC29
9. Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, Royer RE, Vander Jagt DL, Semenza GL, Dang CV (2010) Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A 107:2037-2042. doi:10.1073/pnas.0914433107
10. Shim H, Dolde C, Lewis BC, Wu CS, Dang G, Jungmann RA, Dalla-Favera R, Dang CV (1997) c-Myc transactivation of LDHA: Implications for tumor metabolism and growth. Proc Natl Acad Sci U S A 94:6658-6663 (Pubitemid 27281920)
11. Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330:1340-1344. doi:10.1126/science.1193494/330/6009/ 1340
12. Semenza GL (2010) HIF-1: Upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20:51-56. doi:10.1016/j. gde.2009.10.009/S0959-437X(09) 00168-3
13. Dang CV (2010) Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 70:859-862. doi:10.1158/0008-5472.CAN-09-3556
14. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118:3930-3942. doi:10.1172/JCI36843
15. Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E (2010) Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol 30:1303-1318. doi:10.1128/ MCB.01101-09
16. Shim H, Chun YS, Lewis BC, Dang CV (1998) A unique glucosedependent apoptotic pathway induced by c-Myc. Proc Natl Acad Sci U S A 95:1511-1516 (Pubitemid 28103423)
17. Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y (2007) Deficiency in glutamine but not glucose induces MYCdependent apoptosis in human cells. J Cell Biol 178:93-105. doi:10.1083/jcb.200703099 (Pubitemid 47026405)
18. Tennant DA, Duran RV, Gottlieb E (2010) Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 10:267-277. doi:10.1038/nrc2817
19. Ganapathy-Kanniappan S, Vali M, Kunjithapatham R, Buijs M, Syed LH, Rao PP, Ota S, Kwak BK, Loffroy R, Geschwind JF (2010) 3-Bromopyruvate: A new targeted antiglycolytic agent and a promise for cancer therapy. Curr Pharm Biotechnol 11:510-517. doi:BSP/CPB/E-Pub/0078-11-5
20. Clem B, Telang S, Clem A, Yalcin A, Meier J, Simmons A, Rasku MA, Arumugam S, Dean WL, Eaton J, Lane A, Trent JO, Chesney J (2008) Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 7:110-120. doi:10.1158/1535-7163.MCT-07-0482/7/1/ 110
21. Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC (2008) Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452:181-186. doi:10.1038/nature06667 (Pubitemid 351380242)
22. Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron GJ, Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz JD, Asara JM, Cantley LC (2010) Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329:1492-1499. doi:10.1126/science.1188015/329/5998/1492
23. Vander Heiden MG, Christofk HR, Schuman E, Subtelny AO, Sharfi H, Harlow EE, Xian J, Cantley LC (2010) Identification of small molecule inhibitors of pyruvate kinase M2. Biochem Pharmacol 79:1118-1124. doi:10.1016/j.bcp.2009.12. 003/S0006-2952(09)01060-0
24. Qing G, Skuli N, Mayes PA, Pawel B, Martinez D, Maris JM, Simon MC (2010) Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1alpha. Cancer Res 70:10351-10361. doi:10.1158/0008-5472. CAN-10-0740
25. Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E,Maguire C, Gammer TL, Mackey JR, Fulton D, Abdulkarim B, McMurtry MS, Petruk KC (2010) Metabolic modulation of glioblastoma with dichloroacetate. Science Translational Medicine 2:31ra34. doi:10.1126/scitranslmed.3000677/2/31/31ra34
26. Thomas AA, Le Huerou Y, De Meese J, Gunawardana I, Kaplan T, Romoff TT, Gonzales SS, Condroski K, Boyd SA, Ballard J, Bernat B, DeWolf W, Han M, Lee P, Lemieux C, Pedersen R, Pheneger J, Poch G, Smith D, Sullivan F, Weiler S, Wright SK, Lin J, Brandhuber B, Vigers G (2008) Synthesis, in vitro and in vivo activity of thiamine antagonist transketolase inhibitors. Bioorg Med Chem Lett 18:2206-2210. doi:10.1016/j.bmcl.2007.11.101/S0960-894X(07)01411-4 (Pubitemid 351380849)
27. Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, Wilson KF, Ambrosio AL, Dias SM, Dang CV, Cerione RA (2010) Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18:207-219. doi:10.1016/ j.ccr.2010.08.009/S1535-6108(10)00306-5
28. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812. doi:10.1126/ science.1164382
29. Reitman ZJ, Yan H (2010) Isocitrate dehydrogenase 1 and 2 mutations in cancer: Alterations at a crossroads of cellular metabolism. J Natl Cancer Inst 102:932-941. doi:10.1093/jnci/ djq187
30. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM (2009) Cancerassociated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739-744. doi:10.1038/nature08617
31. Seltzer MJ, Bennett BD, Joshi AD, Gao P, Thomas AG, Ferraris DV, Tsukamoto T, Rojas CJ, Slusher BS, Rabinowitz JD, Dang CV, Riggins GJ (2010) Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1. Cancer Res. doi:10.1158/0008-5472.CAN-10-1666
32. Li M, Smith CJ, Walker MT, Smith TJ (2009) Novel inhibitors complexed with glutamate dehydrogenase: Allosteric regulation by control of protein dynamics. J Biol Chem 284:22988-23000. doi:10.1074/jbc.M109.020222
33. Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: Animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429-439. doi:10.1038/nrc2641
34. Thornburg JM, Nelson KK, Clem BF, Lane AN, Arumugam S, Simmons A, Eaton JW, Telang S, Chesney J (2008) Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res 10: R84. doi:10.1186/bcr2154
35. Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S (2010) Metformin and cancer risk in diabetic patients: A systematic review and meta-analysis. Cancer Prev Res (Phila) 3:1451-1461. doi:10.1158/1940-6207.CAPR-10-0157
36. Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 348 (Pt 3):607-614 (Pubitemid 30410251)